MPCCC Precision Oncology Seminar: Professor Melissa Southey OAM

MPCCC Precision Oncology Seminars are an educational forum in which international and local guest speakers present different perspectives on the latest precision oncology research, clinical trials and treatment options.

Convergence of Public Health and Precision Oncology into Precision Public Health

Management of breast and prostate cancer comprises a large proportion of the work of clinical cancer genetics and oncology services, but translation of findings from basic science into clinical and public health usage remains largely unfulfilled. Genomics (and epigenomics) is one of many factors that can advance precision medicine, but principles of public health remain important to guide the foundation of this work. 

Professor Melissa C. Southey OAM, BSc (Hons, Pathology) PhD (Medicine), GradDip (Law), is a Molecular Geneticist (FHGSA) and a Founding Fellow of the Faculty of Science, Royal College of Pathologists of Australasia (FFSc, RCPA). She is Chair of Precision Medicine, School of Clinical Sciences at Monash Health, Director of Monash University’s new Biobanking Victoria initiative and Research Director of the Monash Partners Comprehensive Cancer Consortium.

Event Details

Friday 25 June, 1-2pm

This event will be held online via Zoom. Zoom joining details will be released one hour before the commencement of the seminar.

Join this webinar

https://monash.zoom.us/j/81598220419?pwd=N3phdTEva1dWQnBxbVpMeXdaT3J6Zz09